TG Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for TG Therapeutics

Access the complete profile.

TG Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	2 Gansevoort St., 9th Floor New York, NY 10014

Note: Revenues for privately held companies are statistical evaluations.


TG Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • TG Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • TG Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

TG Therapeutics Annual Revenue and Growth Rate

TG Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: TG Therapeutics's revenues are gauged from an analysis of company filings.

TG Therapeutics's Income Statement (based on Industry Averages)

TG Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that TG Therapeutics is developing and marketing. TG Therapeutics doesn't have any recent trademark applications, indicating TG Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RYUMSI pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases	06/08/2021
TG PATIENTSUPPORT Financial administration of pharmacy reimbursement programs and services; providing information regarding insurance coverage; and providing financial and insurance information regarding reimbursement for prescription drugs	09/14/2020
UVERSYX Pharmaceutical preparations and substance for the treatment of oncological diseases and disorders	12/02/2019

See all trademarks and details in the Full Report.

Market Share of TG Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as TG Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to TG Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ITI	New York, NY	100
STEMLINE THERAPEUTICS	New York, NY	67
TG THERAPEUTICS	New York, NY	58
POPULATION COUNCIL	New York, NY	53
NEW YORK GENOME CENTER	New York, NY	33
OXFORD NANOPORE TECHNOLOGIES	New York, NY	23

Future Competition: TG Therapeutics's Fastest Growing Competitors

These companies are in the same general field as TG Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)